Ovarian Cancer Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
The global ovarian cancer market is expected to grow at a CAGR of around 11.2% during 2025-2034. This report on global ovarian cancer market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global ovarian cancer market by segmenting the market based on type, treatment type, drugs, end user, and region. Also, detailed profiles of companies operating in the ovarian cancer market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.
Market Drivers
● Rise in the Elderly Women's Population
● Rising Healthcare Awareness
Market Challenges
● Lack of Skilled Professionals
● Unavailability of Adequate Technology
Historical & Forecast Period
Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034
Market by Type
● Epithelial Ovarian Cancer
● Germ Cell Ovarian Cancer
● Stromal Cell Ovarian Cancer
● Primary Peritoneal Cancer
Market by Treatment Type
● Immunotherapy
● Chemotherapy
● Targeted Therapy
● Surgery
● Others
Market by Drugs
● Mitotic Inhibitors
● Antirheumatics
● Antipsoriatics
● VEGF/VEGFR Inhibitors
● PARP Inhibitors
● Antineoplastics
● Others
Market by End User
● Hospitals
● Homecare
● Speciality Centre
● Others
Market by Region
● Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
● North America
United States
Canada
● Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
● Latin America
Mexico
Brazil
Argentina
Rest of Latin America
● Middle East & Africa
Saudi Arabia
Turkey
Iran
United Arab Emirates
Rest of Middle East & Africa
- 1. Preface
- 1.1 Objective
- 1.2 Target Audience & Key Offerings
- 1.3 Report’s Scope
- 1.4 Research Methodology
- 1.4.1 Phase I
- 1.4.2 Phase II
- 1.4.3 Phase III
- 1.5 Assumptions
- 2. Key Insights
- 3. Global Ovarian Cancer Market
- 3.1. Introduction
- 3.2. Market Drivers
- 3.3. Market Challenges
- 4. Global Ovarian Cancer Market Analysis
- 4.1. Market Portraiture
- 4.2. Market Size
- 4.3. Market Forecast
- 4.4. Impact of COVID-19
- 4.5. Impact of Russia-Ukraine War
- 5. Global Ovarian Cancer Market by Type
- 5.1. Introduction
- 5.2. Epithelial Ovarian Cancer
- 5.3. Germ Cell Ovarian Cancer
- 5.4. Stromal Cell Ovarian Cancer
- 5.5. Primary Peritoneal Cancer
- 6. Global Ovarian Cancer Market by Treatment Type
- 6.1. Introduction
- 6.2. Immunotherapy
- 6.3. Chemotherapy
- 6.4. Targeted Therapy
- 6.5. Surgery
- 6.6. Others
- 7. Global Ovarian Cancer Market by Drugs
- 7.1. Introduction
- 7.2. Mitotic Inhibitors
- 7.3. Antirheumatics
- 7.4. Antipsoriatics
- 7.5. VEGF/VEGFR Inhibitors
- 7.6. PARP Inhibitors
- 7.7. Antineoplastics
- 7.8. Others
- 8. Global Ovarian Cancer Market by End User
- 8.1. Introduction
- 8.2. Hospitals
- 8.3. Homecare
- 8.4. Speciality Centre
- 8.5. Others
- 9. Global Ovarian Cancer Market by Region
- 9.1. Introduction
- 9.2. Europe
- 9.2.1. Germany
- 9.2.2. United Kingdom
- 9.2.3. France
- 9.2.4. Italy
- 9.2.5. Spain
- 9.2.6. Russia
- 9.2.7. Netherlands
- 9.2.8. Rest of the Europe
- 9.3. North America
- 9.3.1. United States
- 9.3.2. Canada
- 9.4. Asia Pacific
- 9.4.1. China
- 9.4.2. Japan
- 9.4.3. India
- 9.4.4. South Korea
- 9.4.5. Australia
- 9.4.6. Indonesia
- 9.4.7. Rest of the Asia Pacific
- 9.5. Latin America
- 9.5.1. Mexico
- 9.5.2. Brazil
- 9.5.3. Argentina
- 9.5.4. Rest of Latin America
- 9.6. Middle East & Africa
- 9.6.1. Saudi Arabia
- 9.6.2. Turkey
- 9.6.3. Iran
- 9.6.4. United Arab Emirates
- 9.6.5. Rest of Middle East & Africa
- 10. SWOT Analysis
- 11. Porter’s Five Forces
- 12. Market Value Chain Analysis
- 13. Competitive Landscape
- 13.1. Competitive Scenario
- 13.2. Company Profiles
- 13.2.1. AbbVie
- 13.2.2. Aetera Zenteris Inc.
- 13.2.3. AstraZeneca
- 13.2.4. Boehringer Ingelheim GmbH
- 13.2.5. Bristol-Myers Squibb
- 13.2.6. Clovis Oncology
- 13.2.7. Eli Lilly and Company
- 13.2.8. Genentech Inc.
- 13.2.9. GlaxoSmithKline plc
- 13.2.10. ImmunoGen
- 13.2.11. Janssen Pharmaceuticals, Inc.
- 13.2.12. Johnson & Johnson
- 13.2.13. Novogen, Inc.
- 13.2.14. Oasmia Pharmaceuticals
- 13.2.15. Pfizer
- 13.2.16. Roche Ltd.
- 13.2.17. Tesaro Inc.
- List of Figures
- Figure 1: Global Ovarian Cancer Market (in US$ Million), 2020-2024
- Figure 2: Global Ovarian Cancer Market by Type, 2024
- Figure 3: Global Ovarian Cancer Market by Treatment Type, 2024
- Figure 4: Global Ovarian Cancer Market by Drugs, 2024
- Figure 5: Global Ovarian Cancer Market by End User, 2024
- Figure 6: Global Ovarian Cancer Market by Region, 2024
- Figure 7: Global Ovarian Cancer Market (in US$ Million), 2025-2034
- Figure 8: Global Ovarian Cancer Market by Type (in %), 2024 & 2034
- Figure 9: Global Epithelial Ovarian Cancer Market (in US$ Million), 2020-2024
- Figure 10: Global Epithelial Ovarian Cancer Market (in US$ Million), 2025-2034
- Figure 11: Global Germ Cell Ovarian Cancer Market (in US$ Million), 2020-2024
- Figure 12: Global Germ Cell Ovarian Cancer Market (in US$ Million), 2025-2034
- Figure 13: Global Stromal Cell Ovarian Cancer Market (in US$ Million), 2020-2024
- Figure 14: Global Stromal Cell Ovarian Cancer Market (in US$ Million), 2025-2034
- Figure 15: Global Primary Peritoneal Cancer Ovarian Cancer Market (in US$ Million), 2020-2024
- Figure 16: Global Primary Peritoneal Cancer Ovarian Cancer Market (in US$ Million), 2025-2034
- Figure 17: Global Ovarian Cancer Market by Treatment Type (in %), 2024 & 2034
- Figure 18: Global Immunotherapy Ovarian Cancer Market (in US$ Million), 2020-2024
- Figure 19: Global Immunotherapy Ovarian Cancer Market (in US$ Million), 2025-2034
- Figure 20: Global Chemotherapy Ovarian Cancer Market (in US$ Million), 2020-2024
- Figure 21: Global Chemotherapy Ovarian Cancer Market (in US$ Million), 2025-2034
- Figure 22: Global Targeted Therapy Ovarian Cancer Market (in US$ Million), 2020-2024
- Figure 23: Global Targeted Therapy Ovarian Cancer Market (in US$ Million), 2025-2034
- Figure 24: Global Surgery Ovarian Cancer Market (in US$ Million), 2020-2024
- Figure 25: Global Surgery Ovarian Cancer Market (in US$ Million), 2025-2034
- Figure 26: Global Other Treatment Types Ovarian Cancer Market (in US$ Million), 2020-2024
- Figure 27: Global Other Treatment Types Ovarian Cancer Market (in US$ Million), 2025-2034
- Figure 28: Global Ovarian Cancer Market by Drugs (in %), 2024 & 2034
- Figure 29: Global Mitotic Inhibitors Ovarian Cancer Market (in US$ Million), 2020-2024
- Figure 30: Global Mitotic Inhibitors Ovarian Cancer Market (in US$ Million), 2025-2034
- Figure 31: Global Antirheumatics Ovarian Cancer Market (in US$ Million), 2020-2024
- Figure 32: Global Antirheumatics Ovarian Cancer Market (in US$ Million), 2025-2034
- Figure 33: Global Antipsoriatics Ovarian Cancer Market (in US$ Million), 2020-2024
- Figure 34: Global Antipsoriatics Ovarian Cancer Market (in US$ Million), 2025-2034
- Figure 35: Global VEGF/VEGFR Inhibitors Ovarian Cancer Market (in US$ Million), 2020-2024
- Figure 36: Global VEGF/VEGFR Inhibitors Ovarian Cancer Market (in US$ Million), 2025-2034
- Figure 37: Global PARP Inhibitors Ovarian Cancer Market (in US$ Million), 2020-2024
- Figure 38: Global PARP Inhibitors Ovarian Cancer Market (in US$ Million), 2025-2034
- Figure 39: Global Antineoplastics Ovarian Cancer Market (in US$ Million), 2020-2024
- Figure 40: Global Antineoplastics Ovarian Cancer Market (in US$ Million), 2025-2034
- Figure 41: Global Other Drugs Ovarian Cancer Market (in US$ Million), 2020-2024
- Figure 42: Global Other Drugs Ovarian Cancer Market (in US$ Million), 2025-2034
- Figure 43: Global Ovarian Cancer Market by End User (in %), 2024 & 2034
- Figure 44: Global Hospitals Ovarian Cancer Market (in US$ Million), 2020-2024
- Figure 45: Global Hospitals Ovarian Cancer Market (in US$ Million), 2025-2034
- Figure 46: Global Homecare Ovarian Cancer Market (in US$ Million), 2020-2024
- Figure 47: Global Homecare Ovarian Cancer Market (in US$ Million), 2025-2034
- Figure 48: Global Speciality Centre Ovarian Cancer Market (in US$ Million), 2020-2024
- Figure 49: Global Speciality Centre Ovarian Cancer Market (in US$ Million), 2025-2034
- Figure 50: Global Other End Users Ovarian Cancer Market (in US$ Million), 2020-2024
- Figure 51: Global Other End Users Ovarian Cancer Market (in US$ Million), 2025-2034
- Figure 52: Global Ovarian Cancer Market by Region (in %), 2024 & 2034
- Figure 53: Europe Ovarian Cancer Market (in US$ Million), 2020-2024
- Figure 54: Europe Ovarian Cancer Market (in US$ Million), 2025-2034
- Figure 55: Europe Ovarian Cancer Market by Country (in %), 2024 & 2034
- Figure 56: Germany Ovarian Cancer Market (in US$ Million), 2020-2034
- Figure 57: United Kingdom Ovarian Cancer Market (in US$ Million), 2020-2034
- Figure 58: France Ovarian Cancer Market (in US$ Million), 2020-2034
- Figure 59: Italy Ovarian Cancer Market (in US$ Million), 2020-2034
- Figure 60: Spain Ovarian Cancer Market (in US$ Million), 2020-2034
- Figure 61: Russia Ovarian Cancer Market (in US$ Million), 2020-2034
- Figure 62: Netherlands Ovarian Cancer Market (in US$ Million), 2020-2034
- Figure 63: North America Ovarian Cancer Market (in US$ Million), 2020-2024
- Figure 64: North America Ovarian Cancer Market (in US$ Million), 2025-2034
- Figure 65: North America Ovarian Cancer Market by Country (in %), 2024 & 2034
- Figure 66: United States Ovarian Cancer Market (in US$ Million), 2020-2034
- Figure 67: Canada Ovarian Cancer Market (in US$ Million), 2020-2034
- Figure 68: Asia Pacific Ovarian Cancer Market (in US$ Million), 2020-2024
- Figure 69: Asia Pacific Ovarian Cancer Market (in US$ Million), 2025-2034
- Figure 70: Asia Pacific Ovarian Cancer Market by Country (in %), 2024 & 2034
- Figure 71: China Ovarian Cancer Market (in US$ Million), 2020-2034
- Figure 72: Japan Ovarian Cancer Market (in US$ Million), 2020-2034
- Figure 73: India Ovarian Cancer Market (in US$ Million), 2020-2034
- Figure 74: South Korea Ovarian Cancer Market (in US$ Million), 2020-2034
- Figure 75: Australia Ovarian Cancer Market (in US$ Million), 2020-2034
- Figure 76: Indonesia Ovarian Cancer Market (in US$ Million), 2020-2034
- Figure 77: Latin America Ovarian Cancer Market (in US$ Million), 2020-2024
- Figure 78: Latin America Ovarian Cancer Market (in US$ Million), 2025-2034
- Figure 79: Latin America Ovarian Cancer Market by Country (in %), 2024 & 2034
- Figure 80: Mexico Ovarian Cancer Market (in US$ Million), 2020-2034
- Figure 81: Brazil Ovarian Cancer Market (in US$ Million), 2020-2034
- Figure 82: Argentina Ovarian Cancer Market (in US$ Million), 2020-2034
- Figure 83: Middle East & Africa Ovarian Cancer Market (in US$ Million), 2020-2024
- Figure 84: Middle East & Africa Ovarian Cancer Market (in US$ Million), 2025-2034
- Figure 85: Middle East & Africa Ovarian Cancer Market by Country (in %), 2024 & 2034
- Figure 86: Saudi Arabia Ovarian Cancer Market (in US$ Million), 2020-2034
- Figure 87: Turkey Ovarian Cancer Market (in US$ Million), 2020-2034
- Figure 88: Iran Ovarian Cancer Market (in US$ Million), 2020-2034
- Figure 89: UAE Ovarian Cancer Market (in US$ Million), 2020-2034
- Figure 90: Market Value Chain
- List of Tables
- Table 1: Global Ovarian Cancer Market Portraiture
- Table 2: Global Ovarian Cancer Market by Type (in US$ Million), 2024 & 2034
- Table 3: Global Ovarian Cancer Market by Treatment Type (in US$ Million), 2024 & 2034
- Table 4: Global Ovarian Cancer Market by Drugs (in US$ Million), 2024 & 2034
- Table 5: Global Ovarian Cancer Market by End User (in US$ Million), 2024 & 2034
- Table 6: Global Ovarian Cancer Market by Region (in US$ Million), 2024 & 2034
- Table 7: Europe Ovarian Cancer Market by Country (in US$ Million), 2024 & 2034
- Table 8: North America Ovarian Cancer Market by Country (in US$ Million), 2024 & 2034
- Table 9: Asia Pacific Ovarian Cancer Market by Country (in US$ Million), 2024 & 2034
- Table 10: Latin America Ovarian Cancer Market by Country (in US$ Million), 2024 & 2034
- Table 11: Middle East & Africa Ovarian Cancer Market by Country (in US$ Million), 2024 & 2034
- Table 12: List of Key Players
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook